Research Progress on the Anti-Breast Cancer Effect and Mechanism of Oxymatrine

Authors

  • Tang Xie
  • Shuanglin Tian
  • Mengting Shi
  • Guanhua Ma
  • Yaming Du
  • Xiulan Yang

DOI:

https://doi.org/10.54097/bpe1gh36

Keywords:

OMT, Breast Cancer, Mechanism of Action, Research Progress

Abstract

Oxymatrine (OMT), an alkaloid derived from Sophora flavescens, possesses a diverse array of pharmacological activities, encompassing anti-inflammatory, antiviral, antitumor, and immune regulatory properties. In recent times, significant strides have been made in investigating the efficacy of OMT against breast cancer. OMT exerts its anticancer influence through various mechanisms, including inhibition of tumor cell proliferation, suppression of tumor cell invasion and migration, induction of tumor cell apoptosis, and disruption of the cell cycle. This article systematically reviews the underlying mechanisms of OMT in breast cancer therapy by conducting a comprehensive search across multiple databases, such as CNKI, Wanfang, and PubMed, utilizing keywords like "OMT," "breast cancer," "pharmacology," and "pharmacokinetics," as well as incorporating both Chinese and English terms for "OMT," "triple-negative breast cancer," and "breast cancer." The objective is to delve into the potential applications of OMT in breast cancer treatment and furnish a valuable reference for future clinical investigations exploring the utilization of OMT in this field.

Downloads

Download data is not yet available.

References

[1] Tzeng YT, Hsiao JH, Tseng LM, Hou MF, Li CJ. Breast cancer organoids derived from patients: A platform for tailored drug screening. Biochem Pharmacol. 2023 Nov; 217:115803. Doi: 10.1016 / cp j.b., 2023.115803.

[2] Yan S, Li J, Wu W. Artificial intelligence in breast cancer: application and future perspectives. J Cancer Res Clin Oncol. 2023 Nov; 149(17):16179-16190. doi: 10.1007/s00432-023-05337-2.

[3] Liu X, Luo B, Wu X, Tang Z. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer. Biochim Biophys Acta Rev Cancer. 2023 Nov; 1878 (6) : 189013. Doi: 10.1016 / j.b bcan. 2023.189013.

[4] Verma S, Young S, Boldt G, Blanchette P, Lock M, Helou J, Raphael J. Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys. 2024 Apr 1; 118 (5) : 1422-1434. The doi: 10.1016 / j.i jrobp. 2024.01.001.

[5] Raheem F, Karikalan SA, Batalini F, El Masry A, Mina L. Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches. Int J Mol Sci. 2023 Nov 11; 24(22):16198. doi: 10.3390/ijms242216198.

[6] Verma S, Young S, Boldt G, Blanchette P, Lock M, Helou J, Raphael J. Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys. 2024 Apr 1; 118 (5) : 1422-1434. The doi: 10.1016 / j.i jrobp. 2024.01.001.

[7] Xiao X, Hou X, Shi W, Hu C, Cui Y, Hu J, Piao Z, Zhu X, Li Q, Xu F. Oxymatrine inhibits proliferation and apoptosis of human breast cancer cells through the regulation of miRNA-140-5P. Am J Transl Res. 2021 Dec 15; 13(12):13674-13682. PMID: 35035706; PMCID: PMC8748102.

[8] Xie W, Zhang Y, Zhang S, Wang F, Zhang K, Huang Y, Zhou Z, Huang G, Wang J. Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt/β-Catenin signaling pathway. Am J Cancer Res. 2019 Aug 1; 9(8):1796-1814. PMID: 31497360; PMCID: PMC6726986.

[9] Liu Y, Xu Y, Ji W, et al. Anti-tumor activities of matrine and oxymatrine: literature review[J]. Tumour Biol, 2014, 35(6): 5111-5119.

[10] Lu ML, Xiang XH and Xia SH. Potential signaling pathways involved in the clinical application of oxymatrine[J]. Phytother Res, 2016, 30(7): 1104-1112.

[11] Zhang Mingfa, Shen Yaqin. Research progress on anti-sarcoma pharmacological effect of matrine alkaloids [J]. Drug Evaluation Research, 2018,41 (11):2117-2122. (in Chinese)

[12] Xu Lan, Junnan Zhao, Ying Zhang,et al. Oxymatrine exerts organ-and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis,and fibrosis: from bench to bedside[J]. Pharmacological Research, 2020, 151.

[13] Wu J, Cai Y, Li M, et al. Oxymatrine promotes S-phase arrest and inhibits cell proliferation of human breast cancer cells in vitro through mitochondria-mediated apoptosis[J]. Biol Pharm Bull, 2017, 40(8): 1232-1239.

[14] Liu Yang, Liu Nian, Liu Wen. Synergistic inhibitory effect of oxymatrine combined with 5-FU on growth of human gastric cancer SGC-7901 cells and its mechanism [J]. Chinese Journal of Immunology, 2016, 32(12):447-450.

[15] Cao X, He Q. Anti-Tumor Activities of Bioactive Phytochemicals in Sophora flavescens for Breast Cancer. Cancer Manag Res. 2020 Feb 27;12:1457-1467. doi: 10.2147/ CMAR. S243127. PMID: 32161498; PMCID: PMC7051174.

[16] Huan DQ, Hop NQ, Son NT. Oxymatrine: A current overview of its health benefits. Fitoterapia. 2023 Jul; 168:105565. doi: 10.1016/j.fitote.2023.105565. Epub 2023 Jun 7. PMID: 37295 753.

[17] Marchand LL. Cancer preventive effects of flavonoids: a review [J]. Biomed Pharmacother, 2002,56 (6) : 296-301.

[18] Xiao X, Hou X, Shi W, Hu C, Cui Y, Hu J, Piao Z, Zhu X, Li Q, Xu F. Oxymatrine inhibits proliferation and apoptosis of human breast cancer cells through the regulation of miRNA-140-5P. Am J Transl Res. 2021 Dec 15; 13(12):13674-13682. PMID: 35035706; PMCID: PMC8748102.

[19] Safdari Y, Khalili M, Ebrahimzadeh MA, etal.Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action. Pharmacol Res. 2015; 93:1-10.

[20] Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016; 67:11-28. doi: 10. 1146/annurev-med-062913-051343.

[21] Duong Quang Huan, Nguyen Quang Hop, Ninh The Son,Oxymatrine: A current overview of its health benefits, Fitoterapia, Volume 168202, 3105, 565, ISSN 0367-326 – x.

[22] Guo,L., & Yang, T. (2019). Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway.Cancer Journal of management and research, 11, 10499-10508.

[23] Guo B, Zhang T, Su J, et al. Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. Cancer Chemother Pharmacol. 2017; 75 (2) : 353-363.

[24] Ottewell PD, Donnell L, Holen I, et al. Molecular alterations that drive breast cancer metastasis to bone [J]. Bonekey Rep, 2015, 4:643.

[25] BASU S, CHERIYAMUNDATH S, BEN-ZE'EV A. Cell-cell adhesion: linking Wnt/ β-catenin signaling with partial EMT and stemness traits in tumorigenesis [J]. F1000Res, 2018,18 (7) : 1488-1497.

[26] Han Hua, Cao Yankai, Yin Xin, et al. Research progress of antitumor mechanism of oxymatrine [J]. Modern Zhong 27 [27] Xu Chunlin. Inhibitory effect of oxymatrine on proliferation and invasion of ovarian cancer cells through miR-125B-STAT3 pathway [D]. Hebei Medical University, 2015.

[27] Croce CM, Reed JC. Reed J. Finally, an apoptosis-targeting therapeutic for cancer [J]. Cancer Res, 2016, 76(20) : 5914-5920.

[28] Kashyap D, Garg VK, Goel N. Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Adv Protein Chem Struct Biol. 2021; 125:73-120. Doi: 10.1016 / bs apcsb. 2021.01.003. Epub 2021 Apr 15. PMID: 33931145.

[29] Zhang Dongli, Fu Ruifang, Sun Guixia. Effect of oxymatrine on proliferation and apoptosis of SiHa cells in cervical cancer and its mechanism [J]. Journal of Jilin University (Medical Science Edition),2021,47(in Chinese)

[30] Jiang CY, Han YK, Hu XL, et al. Relative low glycometabolism may also occur in invasive lung adenocarcinoma with visceral pleural invasion: Relative low glycometabolism may also occur in invasive lung Adenocarcinoma with visceral pleural invasion: case report and comments [J]. Medicine, 2014,93 (26) : e254.

[31] Li, Haijun et al. Matrine inhibited proliferation and increased apoptosis in human breast cancer MCF-7 cells via upregulation of Bax and downregulation of Bcl-2. "International journal of clinical and experimental pathology vol. 8,11 14793-9. 1 Nov. 2015.

[32] Xiao X, Hou X, Shi W, Hu C, Cui Y, Hu J, Piao Z, Zhu X, Li Q, Xu F. Oxymatrine inhibits proliferation and apoptosis of human breast cancer cells through the regulation of miRNA-140-5P. Am J Transl Res. 2021 Dec 15; 13(12):13674-13682. PMID: 35035706; PMCID: PMC8748102.

[33] Jamasbi E, Hamelian M, Hossain MA, Varmira K. The cell cycle, cancer development and therapy. Mol Biol Rep. 2022 Nov; 49(11):10875-10883. doi: 10.1007/ s11033-022-07788-1.Epub 2022 Aug 5.PMID: 35931874.

[34] Wang J, Yang Y, Sheng Y J, et al. Study on the mechanism of micrornA-122 reducing Warburg effect and inhibiting proliferation and invasion of breast cancer cells [J]. Zhejiang Medical Journal, 2019,41 (16) : 1696-1700, 1804.

[35] Dowsett M, Nielsen TO, Ahern R, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in breast cancer working group [J]. Assessment of Ki67 in breast cancer: Recommendations from the international Ki67 in breast cancer working group. J Natl Cancer Inst, 2011,103 (22) : 1656-1664.

[36] Wu Shasha, Li Wenyan, Wang Jin. Effect of oxymatrine on metabolic reprogramming of breast cancer cells by enhancing miRNA-122 [J]. Traditional Chinese medicine, 2021, 44 (6) : 1477-1482. The DOI: 10.13863 / j.i ssn1001-4454.2021.06.033.

[37] Wu J, Cai Y, Li M, Zhang Y, Li H, Tan Z. Oxymatrine Promotes S-Phase Arrest and Inhibits Cell Proliferation of Human Breast Cancer Cells in Vitro through Mitochondria-Mediated Apoptosis. Biol Pharm Bull. 2017; 40(8):1232-1239. doi: 10.1248/ bpb.b17-00010.PMID: 28769005.

[38] Annan, Chen Ziqi, Huang Min. Research progress of vascular endothelial cell metabolism and tumor angiogenesis. Acta Pharmacologica Sinica, 2020, 55: 1373-81.

[39] Zong Ruyue, Luo Xinpeng, Lu Xiaochao, et al. Angiogenesis in malignant tumor and the research progress of targeted therapy strategies [J]. Journal of life science, 2022 (6) : 644-652. The DOI: 10.13376 / j.carol carroll BLS / 2022074.

[40] Lopes-Coelho, F.; Martins, F.; Pereira, S.A.; Serpa, J. Anti-Angiogenic Therapy: Current Challenges and Futue Perspectives. Int. J. Mol. Sci. 2021, 22, 3765.

[41] Xu Zhe, Wang Zhe, Zhao Wei, et al. On the treatment of tumor from the perspective of combination of disease and Syndrome -- Interview with Professor Jia Yingjie. [J]. Journal of Tianjin University of Traditional Chinese Medicine, 201,40(3):273-276.

[42] Zhang Beibei, Zhang Yan, Wang Fengxian, et al. Study on the mechanism of antioxidative matrine combined with bevacizumab against breast cancer in vitro based on Wnt/β-catenin regulation of EMT [J]. Chinese journal of experimental formulas of Chinese medicine, 2021, 27 (24) : 109-117. The DOI: 10.13422 / j.carol carroll nki syfjx. 20212423.

[43] Hong Wang, Liangyin Wei, Dengxuan Mao, Xiaoyu Che, Xietao Ye, Yuping Liu, Yan Chen,Combination of oxymatrine (Om) and astragaloside IV (As) enhances the infiltration and function of TILs in Tripe - negative breast cancer (TNBC), International Immunopharmacology, Volume 125, Part A, 2023111, 026, ISSN 1567-5769.

[44] Ni Xue. Inhibitory effect of oxymatrine combined with UTD1 on proliferation of human breast cancer MCF-7 cell line [D]. Liaoning university of traditional Chinese medicine, 2022. DOI: 10.27213 /, dc nki. GLNZC. 2022.000270.

Downloads

Published

10-12-2024

Issue

Section

Articles

How to Cite

Xie, T., Tian , S., Shi, M., Ma, G., Du, Y., & Yang, X. (2024). Research Progress on the Anti-Breast Cancer Effect and Mechanism of Oxymatrine. Journal of Education and Educational Research, 11(3), 34-38. https://doi.org/10.54097/bpe1gh36